Skip to main content

Ruptured Aneurysms Treated With Hydrogel Coils

Status unknown · NCT03252314

Conditions: Ruptured Aneurysm

At a glance

Research payments reported, 2025
$504,284
U.S. investigators named
34
Sites paid
32
Planned or actual enrollment
1,000

About the trial

Sponsor
Microvention-Terumo, Inc. (with Semmes-Murphey Foundation)
Tested
Second-generation hydrogel coils (device)
Dates
Started 2017-11-27; completion 2025-12
Results posted
Not yet

To determine safety and occlusion rates when second-generation hydrogel coils are used in the treatment of ruptured intracranial aneurysms.

From ClinicalTrials.gov, last updated 2024-07-23. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Microvention, Inc. reported $504,284 in research payments for this study in 2025 (86 payments).

Products named: Hypersoft Advanced, Hydrosoft Advanced

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.